Resultados a tres años de seguimiento de Fasciotomía percutánea con aguja en enfermedad de Dupuytren / Results after three years of follow-up of percutaneous fasciotomy with needle in Dupuytren's disease
Rev. méd. Maule
;
33(2): 25-30, sept. 2018. ilus, graf
Article
in Spanish
| LILACS
| ID: biblio-1292509
ABSTRACT
Dupuytren's disease is the abnormal and progressive proliferation of the palmar fascia, its etiology remains unknown. Percutaneous needle fasciotomy is a minimally invasive procedure, where hypodermic needles are used as a scalpel blade to break the pathological cord in Dupuytren's disease. OBJECTIVE:
To evaluate the results of percutaneous needle fasciotomy in patients with 3-year follow-upMETHODS:
Percutaneous needle fasciotomy was performed in patients from the regional hospital of Talca from January 2014 to January 2017, pre and post-procedure contracture measurement was performed, followed up at 6 weeks, 3 months and annually up to three years. there was a registry of complications, recurrence and functional results with the QuickDASH scale.RESULTS:
Of the 17 patients chosen, 13 completed the follow-up. 15 fingers (5 little fingers, 9 ring fingers, 1 middle) and 23 joints. The metacarpophalangeal joints achieved an immediate correction of 89%, maintaining a correction of 48% at three years. The proximal interphalangeal joint achieved a correction of 62%, maintaining 32% at the end of the follow-up. The QuickDash managed to descend from 39.4 to 21.5 points. There was recurrence of 35.7% in the metacarpophalangeal joints and 42.8% in proximal interphalangeal joints. We found that percutaneous fasciotomy is a treatment option.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Dupuytren Contracture
/
Fasciotomy
/
Needles
Limits:
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Maule
Journal subject:
Medicine
Year:
2018
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Hospital Regional de Talca/CL
/
Hospital de Talca/CL
/
Universidad Católica del Maule/CL
Similar
MEDLINE
...
LILACS
LIS